Sandip Jain, MD
Neurology · Greenville, SCNPI 1750456869
Payments from drug & device makers
Across 513 payments — averaging $83.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$22K
- Argenx US, Inc.$10K
- Novartis$2K
- EDW Pharma, Inc.$2K
- AbbVie$826
- Neurocrine Biosciences, Inc.$631
- plus $6K from 46 others
What the payments were for
- Consulting fees$19,98847%
- Speaking & faculty fees$7,72818%
- Travel & lodging$2,8607%
- Food & beverage$10,83325%
- Education$4471%
- Gifts$9532%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UPLIZNA$13,238
- VYVGART HYTRULO$7,345
- Tiglutik$1,542
- MAYZENT$890
- VNS Therapy$575
- Mavenclad$205
How this compares
$42,809 in reported general payments places this provider in the 85th percentile of 270 neurology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 83 | $448,882 |
| EvrysdiRisdiplam | 13 | $343,440 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 17 | $314,278 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 30 | $183,447 |
| Kesimpta PenOfatumumab | 15 | $152,261 |
| XembifyImmune Globulin,gamma(Igg)klhw | 12 | $95,083 |
| NuplazidPimavanserin Tartrate | 14 | $71,138 |
| Glatiramer Acetate | 14 | $37,632 |
| Aimovig AutoinjectorErenumab-Aooe | 49 | $37,299 |
| UbrelvyUbrogepant | 18 | $37,167 |
| Emgality PenGalcanezumab-Gnlm | 27 | $22,425 |
| Dalfampridine ErDalfampridine | 33 | $14,799 |
| KeppraLevetiracetam | 12 | $13,655 |
| Dimethyl Fumarate | 33 | $8,545 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 92 | $6,590 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Grifols USA, LLCGamunex-C, Xembify | $128 | $543,96595 claims |
| Genentech USA, Inc.Evrysdi | $201 | $343,44013 claims |
| CSL BehringPrivigen | $192 | $314,27817 claims |
| Acadia Pharmaceuticals IncNuplazid | $236 | $71,13814 claims |
| AbbVieUbrelvy | $826 | $37,16718 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide, Mycophenolate Mofetil | $42 | $8,03979 claims |
| Upsher-smith Laboratories LLCTopiramate | $32 | $62057 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 270 neurology providers in South Carolina.
Other neurology in Greenville
- Mary HughesGreenville$6.3M
- Fredy RevillaGreenville$475K
- Kathleen WoschkolupGreenville$110K
- John AbsherGreenville$30K
- Amber StutzGreenville$26K
- John PorterGreenville$17K
- William McElveenColumbia$3.7M
- Robert CarlileSummerville$2.3M
- Andrew KeeganCharleston$2.2M
- Paul MazzeoPort Royal$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.